The New Selinexor Myeloma Community Support Group
MC EVENTS - January 26, 2021
The Myeloma Crowd Community is launching the first-ever online support group focused on a novel drug treatment—XPOVIO ® or selinexor—on Wed... Read More
American Society of Hematology Meeting Review: Register Now for the Myeloma Crowd Round Table Interactive Webcast on January 30
UPCOMING MC ROUND TABLES - January 23, 2021
Six Myeloma Experts Discuss ASH Studies Register Now The American Society of Hematology (ASH) meeting is the most important scientific... Read More
A New Treatment Option for Relapsed Myeloma Targeting MAPK Signaling
A New Treatment Option for Relapsed Myeloma Targeting MAPK Signaling
MYELOMA NEWS - January 22, 2021
A new treatment option for relapsed myeloma may be available via the MAPK signaling pathway. Multiple myeloma patients learn all sorts of fancy ne... Read More
HealthTree University: Know Your Therapy (BETA) (Part 3 of 3)
HEALTHTREE - January 21, 2021
Editor’s note: These videos are still in the editing stages, but they have important information about your disease and the myeloma therapies pat... Read More
Darzalex FASPRO Receives FDA Approval for AL Amyloidosis
MYELOMA NEWS - January 21, 2021
Darzalex FASPRO® (the subcuteneous injectable version of daratumumab) with bortezomib, cyclophosphamide and dexamethasone is now the first FDA-approved... Read More
Optimism for Federal Medical Research Support
MC NEWSROOM - January 21, 2021
President Biden’s past strong support for cancer research is inspiring cautious confidence among cancer advocates that medical and cancer research may bec... Read More
New Rules for Healthcare Costs Disclosure and Surprise Billing
MYELOMA COACH - January 20, 2021
In December, the Trump administration made two rules regarding medical costs disclosure as well as surprise billing: Healthcare Price Disclosure The healt... Read More
The Positive Effect of Consolidation Therapy in Multiple Myeloma
MYELOMA NEWS - January 18, 2021
It always interesting to talk to fellow multiple myeloma patients and learn about different treatment regimens and experiences they have had compared to ou... Read More
MCRT Webcast: High-Risk Disease Essentials
MC ROUND TABLES - January 16, 2021
High-risk disease poses the most difficult questions in myeloma treatment. Increasing knowledge about genetics provides information about which targets to... Read More
Change is Possible: Achieve your Myeloma Goals in 2021 with the Help of a Myeloma Coach
MYELOMA COACH - January 15, 2021
The start of a brand new year feels fresh and inspiring. It's a clean slate, a new start. It’s no wonder that this is the time many commit to new... Read More
HealthTree University: Know Your Therapy (BETA) (Part 2 of 3)
HEALTHTREE - January 14, 2021
Editor’s note: These videos are still in the editing stages, but they have important information about your disease and the myeloma therapies pat... Read More
Blood Type and Multiple Myeloma Outcomes
LIFE WITH MYELOMA - January 13, 2021
Does blood type matter when it comes to multiple myeloma? Turkish researchers shared new data in the Magazine of European Medical Oncology showing tha... Read More
Pesticide Use Linked to Myeloma Precursor Conditions
LIFE WITH MYELOMA - January 12, 2021
A recent study of male farmers shows that the use of certain types of pesticides are associated with the precursor condition of multiple myeloma called&nbs... Read More
